| Financial Year |
March 31 2023 |
| Monetary Funds |
7,648,553,362.88 |
| Held-for-trading Financial Assets |
250,481,573.92 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,783,354,944.10 |
| Advances to Suppliers |
149,907,678.36 |
| Other Receivables |
880,517,614.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
237,598,983.89 |
| Inventories |
62,962,728.11 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
54,300,113.15 |
| Other Current Assets |
399,770,225.41 |
| Total Current Assets |
11,229,848,240.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
399,120,224.05 |
| Long-term Equity Investment |
457,493,427.44 |
| Investment Properties |
-- |
| Fixed Assetes |
4,889,729,247.25 |
| Under-construction Projects |
527,193,874.24 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
6,857,033,464.48 |
| R&D expenses |
-- |
| Goodwill |
11,174,542,354.19 |
| Long-Term Deferred and Prepaid Expenses |
1,421,863,448.24 |
| Deferred Income Tax Assets |
999,118,973.22 |
| Other Non-Current Assets |
1,553,003,091.72 |
| Sub-Total of Non-Current Assets |
37,014,477,238.36 |
| Total Assets |
48,244,325,478.56 |
| Short-Term Loans |
214,533,372.92 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,242,347,319.08 |
| Accounts Received In Advance |
7,870,772.09 |
| Employee Compensation Payable |
941,716,028.07 |
| Taxes Payable |
384,406,794.04 |
| Interest Payable |
-- |
| Dividend Payable |
138,549,429.51 |
| Other payables |
2,155,380,253.86 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,633,508,857.57 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
12,364,414,191.39 |
| Long-term Loans |
8,203,240,048.34 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
5,953,810.67 |
| Special Payable |
-- |
| Estimatied Liabilities |
45,326,613.65 |
| Deferred Income Tax Liabilities |
1,817,957,638.68 |
| Other Non-Current Liabilities |
150,909,632.01 |
| Sub-Total of Non-Current Liabilities |
18,541,470,977.52 |
| Total Liabilities |
30,905,885,168.91 |
| Paid-In Capital(Or Share Stock) |
1,070,044,063.00 |
| Capital Surplus |
12,502,750,102.00 |
| Surplus Reserve |
715,703,320.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,446,122,222.26 |
| Minority Stockholder's Interest |
634,717,159.90 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
16,703,723,149.75 |
| Owner's Equity（Stockholder's Equity） |
17,338,440,309.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
48,244,325,478.56 |
